ProPhase Labs, Inc. — Director's Dealing 2024

Mar 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2024-03-17

Reporting Person: Barr Jason Michael (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-17	Option (right to buy)	$6.00	A	70000	Acquired	2031-03-17	Common Stock (70000)	Direct

Footnotes

F1: Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date.